← Open Payments lookup

DIANA REMENAR: Open Payments

NPI 1174046619 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,328 in 144 payments from 17 companies in 2025. Trend: 2023 $3,246 · 2024 $2,765 · 2025 $2,328

Food & beverage: $2,328
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.21$376
ABBVIE INC.40$306
Otsuka America Pharmaceutical, Inc.13$257
Vanda Pharmaceuticals Inc.13$243
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$239
Neurocrine BioSciences, Inc.10$200
Lundbeck LLC6$105
E.R. Squibb & Sons, L.L.C.5$103
Janssen Pharmaceuticals, Inc4$98
Takeda Pharmaceuticals U.S.A., Inc.4$75

Products named: AUSTEDO XR, REXULTI, VRAYLAR, FANAPT, CAPLYTA, INGREZZA, COBENFY, SPRAVATO.

Industry payments across NC — which companies pay providers there.